Trends in Manufacturing eBook
Pharmaceutical Technology's Trends in Manufacturing eBook
Read the article:
Read the eBook:
Virtual and augmented reality have emerged as critical digital training tools.
andrush - adobe.stock.com
While a conclusive ‘end’ to the pandemic remains elusive, the transition to a post-pandemic economic model has been defined by a mass ramp-up of various means of digital communication. Digital training tools are one such solution, often allowing companies to effectively prepare employees for the job before they even set foot on-site. While these tools can take on many forms, of particular prominence are augmented reality (AR) and virtual reality (VR) visualization technologies.
Read this article in Pharmaceutical Technology's Trends in Manufacturing eBook.
Read the article:
Read the eBook:
Grant Playter is the Assistant Editor at Pharmaceutical Technology.
Pharmaceutical Technology
eBook: Trends in Manufacturing
May 2022
Pages: 58–59
When referring to this article, please cite it as G. Playter, "Embracing New Realities," Pharmaceutical Technology's Trends in Manufacturing eBook (May 2022).
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia
June 9th 2025The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.